nonprofit logo

Usher Iii Initiative Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 272523450 ✦ Chicago, IL ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Usher Iii Initiative Inc?

Usher III Initiative Inc, based in Chicago, Illinois, is a nonprofit organization dedicated to exploring potential treatments for Usher Syndrome Type 3. Their mission involves identifying therapies, treatments, and ultimately, a cure for this condition. The initiative has pursued a strategic approach, focusing on small molecule chaperone therapy, aiming to slow or potentially reverse the vision loss associated with Usher III. Their primary activity includes conducting research, pre-clinical safety studies, and manufacturing of a lead drug compound for this purpose.


Official website here: www.usheriii.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 96%, Four-Star out of Four Star rating.

The Usher Iii Initiative Inc has demonstrated high standards in accountability and finance, achieving an impressive 96% score. This rating indicates a strong commitment to transparency and effective financial management practices, reflecting the organization’s responsibility toward its donors and stakeholders. The overall score is derived solely from its Accountability & Finance beacon, highlighting a concentrated effort in these areas.

Notably, the organization boasts a fully independent board, with 100% of its members meeting this criterion. Additionally, it has a high program expense ratio of approximately 94%, suggesting that most of its resources are directed toward its mission rather than administrative costs. This financial efficiency is further supported by the absence of any material diversion of assets.

While the organization excels in various financial metrics and policies, the summary does not provide insights into its programmatic impact or community feedback. Future evaluations may benefit from exploring these dimensions to give a more comprehensive view of the organization's effectiveness in fulfilling its mission.


This AI summary has been generated from information found on Charity Navigator.

Is Usher Iii Initiative Inc legitimate?

Usher Iii Initiative Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Usher Iii Initiative Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.usheriii.org

What is the mission statement of Usher Iii Initiative Inc?

The Usher III Initiative Inc's mission is centered around identifying potential therapies, treatments, and ultimately, a cure for Usher Syndrome Type III. Their primary objective is to develop a treatment that can slow down or potentially reverse the vision loss associated with this condition. To achieve this goal, the initiative has adopted an approach focused on small molecule chaperone therapy. Currently, they are engaged in the continued development of a lead drug compound for Usher Syndrome Type 3, involving research, pre-clinical safety studies, and manufacturing processes.


Official website here: www.usheriii.org

Who is the CEO of Usher Iii Initiative Inc?

Alicia Derrah is the President of Usher Iii Initiative Inc.


Official website here: www.usheriii.org

What is the revenue of Usher Iii Initiative Inc?

Usher Iii Initiative Inc's revenue in 2022 was $1,771,984.


Official website here: www.usheriii.org

Who are the executives of Usher Iii Initiative Inc and what are their salaries?

There 10 volunteers at Usher Iii Initiative Inc.


Here are 8 key members and their salaries:


Cynthia Elden (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mark Ackermann (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Julia Hayes (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
James C Murray (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr David Saperstein (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Kraines (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Paul Sternberg Jr (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alicia Derrah (Treasurer, Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.usheriii.org

Where can I find the form 990 for Usher Iii Initiative Inc?

Usher Iii Initiative Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.usheriii.org

Learn more at the official website: www.usheriii.org

Mission Statement of Usher Iii Initiative Inc

The Usher III Initiative Inc is committed to identifying potential therapies, treatments, and, ultimately, a cure for Usher Syndrome Type III. Their primary goal is to develop a treatment that can slow down or potentially reverse the vision loss associated with this condition. To achieve this, the initiative has adopted an approach centered on small molecule chaperone therapy. Currently, they are focused on furthering the development of a lead drug compound for Usher Syndrome Type 3, involving rigorous research, pre-clinical safety studies, and manufacturing processes.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Usher Iii Initiative Inc is dedicated to identifying therapies and treatments for Usher Syndrome Type III, significantly impacting the lives of individuals affected by this condition. By focusing on the development of a lead drug compound aimed at treating Usher Syndrome type 3, the initiative actively undertakes essential research, pre-clinical safety studies, and manufacturing processes. Located in Chicago, Illinois, it emphasizes a unique approach that centers on small molecule chaperone therapy, which seeks to slow or potentially reverse the vision loss associated with Usher Syndrome III. This initiative not only fosters hope within the affected community but also drives forward scientific understanding and advancements in treating this rare disorder.




This information is meant to be a general summary of Usher Iii Initiative Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$1,771,984 (2022)
Expenses
$924,491 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $975
  • Gross Receipts: $1,771,984

Assets and Liabilities:

  • Total Assets: $2,080,401
  • Total Liabilities: $118,224
  • Net Assets: $1,962,177

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2010

Principal Officer

Alicia Derrah

Main Address

191 N WACKER DRIVE 1790, CHICAGO, IL, 60606

NTEE Category

Code: G122 - Disease

If you are a representative of Usher Iii Initiative Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.